Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens

AIMS: Intraductal carcinoma (IDC) is an adverse histopathological parameter for prostate cancer outcome, but is not incorporated in current tumour grading. To account for its dismal prognosis and to omit basal cell immunohistochemistry, it has been proposed to grade IDC on the basis of its underlyin...

Descripción completa

Detalles Bibliográficos
Autores principales: Rijstenberg, L. Lucia, Hansum, Tim, Hollemans, Eva, Kweldam, Charlotte F, Kümmerlin, Intan P, Bangma, Chris H, van der Kwast, Theodorus H, Roobol, Monique J, van Leenders, Geert J L H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692905/
https://www.ncbi.nlm.nih.gov/pubmed/32542746
http://dx.doi.org/10.1111/his.14179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692905/
https://www.ncbi.nlm.nih.gov/pubmed/32542746
http://dx.doi.org/10.1111/his.14179

Ejemplares similares